Original article by Sarah Danckert
The Australian Financial Review – Page: 3 : 3-Jul-15

Two former senior executives of Australian-listed Sigma Pharmaceuticals will return to court in September 2015, after pleading guilty to charges of falsifying the group’s financial accounts. Elmo de Alwis was CEO until 2010, while Mark Smith stepped down as CFO in the same year. They have also been charged with providing false and misleading statements to the group’s board of directors and auditors.

CORPORATES
SIGMA PHARMACEUTICALS LIMITED – ASX SIP, COUNTY COURT OF VICTORIA, AUSTRALIAN SECURITIES AND INVESTMENTS COMMISSION